An attenuated strain of Bacillus anthracis (CDC 684) has a large chromosomal inversion and altered growth kinetics
- Richard T Okinaka1, 2Email author,
- Erin P Price1,
- Spenser R Wolken1,
- Jeffrey M Gruendike1,
- Wai Kwan Chung1,
- Talima Pearson1,
- Gary Xie2,
- Chris Munk2,
- Karen K Hill2,
- Jean Challacombe2,
- Bruce E Ivins^3,
- James M Schupp4,
- Stephen M Beckstrom-Sternberg1, 4,
- Arthur Friedlander3 and
- Paul Keim1, 2, 4
© Okinaka et al; licensee BioMed Central Ltd. 2011
Received: 11 May 2011
Accepted: 30 September 2011
Published: 30 September 2011
An isolate originally labeled Bacillus megaterium CDC 684 was found to contain both pXO1 and pXO2, was non-hemolytic, sensitive to gamma-phage, and produced both the protective antigen and the poly-D-glutamic acid capsule. These phenotypes prompted Ezzell et al., (J. Clin. Microbiol. 28:223) to reclassify this isolate to Bacillus anthracis in 1990.
We demonstrate that despite these B. anthracis features, the isolate is severely attenuated in a guinea pig model. This prompted whole genome sequencing and closure. The comparative analysis of CDC 684 to other sequenced B. anthracis isolates and further analysis reveals: a) CDC 684 is a close relative of a virulent strain, Vollum A0488; b) CDC 684 defines a new B. anthracis lineage (at least 51 SNPs) that includes 15 other isolates; c) the genome of CDC 684 contains a large chromosomal inversion that spans 3.3 Mbp; d) this inversion has caused a displacement of the usual spatial orientation of the origin of replication (ori) to the termination of replication (ter) from 180° in wild-type B. anthracis to 120° in CDC 684 and e) this isolate also has altered growth kinetics in liquid media.
We propose two alternative hypotheses explaining the attenuated phenotype of this isolate. Hypothesis 1 suggests that the skewed ori/ter relationship in CDC 684 has altered its DNA replication and/or transcriptome processes resulting in altered growth kinetics and virulence capacity. Hypothesis 2 suggests that one or more of the single nucleotide polymorphisms in CDC 684 has altered the expression of a regulatory element or other genes necessary for virulence.
Attenuated strains of Bacillus anthracis have played a major role in the development of vaccines and our understanding of anthrax. Early work by Pasteur and Greenfield [1, 2] capitalized upon strains missing one of the mega-plasmids (pXO1), which resulted in attenuation. This enabled the development of the first bacterial disease to be prevented through the use of an attenuated live vaccine. This early work was improved by Sterne  through the development of an attenuated strain missing the second mega-plasmid (pXO2), but retaining the toxin producing genes on pXO1 as antigens for immune response. In recent years, avirulent strains have been subjected to extensive DNA sequencing to understand these plasmids, their virulence genes and to generate hypotheses for attenuation mechanisms [4–11]. Conversely B. cereus strains that have acquired the known B. anthracis mega-plasmids and anthrax-like virulence properties remain an enigma and are also worthy of further study to understand how this pathogen interacts with its host [12–14].
An isolate from the Centers for Disease Control (CDC) originally identified as B. megaterium, CDC 684/NRRL-349S/NRS 234 (herein called CDC 684), was being used as an avirulent outgroup control in experiments with B. anthracis. However, this particular isolate shares key phenotypic traits with B. anthracis such as non-hemolytic on blood agar, production of protective antigen and the poly-D-glutamic acid capsule, and sensitivity to gamma bacteriophage. Because these features are all hallmark phenotypes for B. anthracis, Ezzell et al.  reclassified this isolate as B. anthracis despite the observation that CDC 684 did not react with monoclonal antibodies to a specific polysaccharide present in B. anthracis. Subsequent animal testing of this isolate showed it to be severely attenuated in guinea pigs, in contrast to wild-type B. anthracis (See results, Attenuation of CDC 684). However, the underlying mechanism behind this attenuated virulence phenotype remained unknown. The advent of massively parallel whole genome sequencing (WGS) provides an opportunity to examine the complete genetic component of CDC 684 for clues that might bear on this problem.
This report provides a description of the WGS, assembly and annotation of the B. anthracis CDC 684 isolate. We include analysis that: a) demonstrates that the genome of CDC 684 belongs to a specific B. anthracis clade; b) identifies 51 single nucleotide polymorphisms (SNP) that are unique to the genome of this isolate; c) describes the details of a large chromosomal inversion; d) demonstrates that CDC 684 has altered growth kinetics in culture and e) proposes two alternative and testable hypotheses that could explain the attenuated phenotype for CDC 684.
Attenuation of CDC 684
The discovery that CDC 684 was not a B. megaterium strain but was rather B. anthracis, based on shared phenotypic features, prompted the use of the guinea pig model to determine its virulence. In a pilot experiment, groups of four guinea pigs injected i.m. with CDC 684 spores at doses of 114, 1,145, and 11,450 cfu/mL survived. These groups were then injected four days later with 1.29 × 105, 1.29 × 106 and 1.29 × 107 cfu/mL, respectively, and again all survived. By comparison these identical spore preparation and treatment conditions produced LD50 values for the virulent Ames and Vollum-1B strains of 175 and 306 spores respectively in the guinea pig model [16, 17].
This lack of lethality indicated that CDC 684 is significantly attenuated. In a second experiment to confirm attenuation, 10 guinea pigs injected i.m. with 1 × 108 cfu/mL CDC 684 spores all survived. These results confirm that CDC 684 is highly attenuated with an LD50 of >1 × 108 spores in the guinea pig model.
WGS of CDC 684
The CDC 684 genome has been recently sequenced and assembled to closure at Los Alamos National Laboratory/J. Craig Venter Institute and is available on the NCBI Genome database [GenBank: CP001215.1]. The chromosome is 5,230,115 bp, pXO1 [GenBank: CP001216] is 181,773 bp and pXO2 [GenBank: CP001214] is 94,875 bp.
Phylogenetic placement of CDC 684
The use of comparative WGS defined an extremely conserved and accurate phylogenetic SNP tree for B. anthracis based on the analysis of 1,000 SNPs in 26 diverse isolates . This analysis resulted in the hypothesis that only a few selected SNPs at key positions along five branches were needed to accurately place all B. anthracis isolates into one of 12 sub-clades. This notion was shown to be accurate when 13 canSNPs were subsequently used to accurately place more than 1,000 B. anthracis isolates into one of these 12 sub-clades . In silico canSNP typing showed that CDC 684 falls along the lineage created by B. anthracis Vollum (A0488; [GenBank: ABJC00000000]). This sequenced Vollum strain is presumed to be a close relative of the British isolate that was tested as a biological weapon on Gruinard Island, Scotland, in the 1940s .
The close phylogenetic relationship between CDC 684 and Vollum demonstrates that CDC 684 belongs to a highly virulent B. anthracis lineage. We were therefore interested in further determining the degree of relatedness between Vollum and CDC 684, given the marked differences in virulence between these two strains. An initial comparative in silico analysis of Ames Ancestor [GenBank: AE017334], CDC 684 and Vollum WGS uncovered ~ 390 SNP differences distinct from Ames Ancestor but common (i.e., derived) in both the CDC 684 and Vollum genomes. These results are consistent with other whole genome SNP comparisons of 128 B. anthracis isolates that suggest that the SNP genetic distance between Ames and Vollum is approximately 400 SNPs [Pearson, Schupp, Ravel and Keim, unpublished data].
CDC specific SNPs
This analysis also demonstrated that CDC 684 possessed 51 SNPs that appeared to be unique to this isolate. There were 15 isolates that shared the Vollum branch node with CDC 684. These isolates were predominantly recovered by the Centers for Disease Control during the 1950s and 1960s. While the incidence of lethal anthrax infections in the United States had been greatly reduced during the 20th century , it can be assumed that the majority of the CDC isolates labeled as B. anthracis would have come from sources containing virulent strains such as imported hides and/or animal deaths .
CDC 684 specific non-synonymous SNPs indicating chromosomal positions, gene products and amino acid changes
ABC transporter, substrate binding
Amino Acid permease family
ABC phosphate binding protein
PAP 2 family protein
Major facilitator transporter
Conserved hypothetical protein
Non-ribosomal peptide synthetase
Putative membrane protein
Conserved hypothetical protein
Conserved hypothetical protein
Phosphate butyryl transferase
RNA polymerase sigma-43
CBS domain protein
Conserved hypothetical protein
SpoVA family protein
Conserved hypothetical protein
ABC transporter, ATP-binding
RNA helicase, DEAD/DEAH box
Sequence variations between the virulence plasmids
The simplest explanation for the attenuated phenotype for CDC684 would be the mutation of one or more of the virulence factors encoded on the pXO1 or pXO2 plasmids that altered expression or function. These virulence factors include the toxin gene complex on pXO1 (comprising genes encoding for protective antigen, edema factor, and lethal factor), the poly-D-glutamyl capsule gene complex on pXO2 (encoded by capA, capB, capC and acpA), and trans-acting transcription regulators on both plasmids . However, in silico comparison of the completed sequences of the pXO1 and pXO2 plasmids from the CDC 684 strain to those of the Ames Ancestor and Vollum strains showed that all of the known virulence factors were intact. There was a single non-synonymous SNP found in pXO1 GBAA_pXO1_0019, a large gene of unknown function. Collectively we observed no putative functional differences in the plasmid-encoded virulence factors between CDC 684 and its closest relative, Vollum, which is a fully virulent strain .
Large chromosomal inversion in CDC 684
The inversion appears to have been caused by an internal recombination event between homologous regions within two lysogenic lambda-like prophages (LambdaBa04 and LambdaBa02), which are found in all B. anthracis genomes [26, 27]. The inversion can best be visualized at the molecular level by examining the orientation of the att (attachment) sites that flank the ends of these phages (Figure 2). Lysogenic bacteriophages possess cohesive ends (att), usually 12-13 bp repeats, which serve as both excision points and "sticky ends" that enable the phage to cirularize as it enters a lytic life cycle . At first glance it seemed likely that the inversion may involve the att sites in these Lambda like prophages and that the exchange may have involved a site-specific recombination. But the two att sites were unique to each other, i.e., Lambda Ba04 and Ba02 contain distinct att sites (Figure 2B) that allow them to be distinguished from each other (Ba04, ATACAGCTCATGT and Ba02, TTTT(C/T)TTTACAC). In Ames Ancestor, pairs of these two distinct att sites define both the size (Ba04 = 37.3 kb; Ba02 = 44.0 kb) and boundaries of each prophage. In CDC 684 (Figure 2A), the external att sites (represented by black bars) are in relatively identical chromosomal positions to those in the Ames Ancestor. However, the internal att sites (represented by green and red bars) have dramatically exchanged positions between these genomes. In CDC 684, the right att site (red bar) for LambdaBa04 has moved to the left att position of Lambda Ba02, and likewise the left att site for Lambda Ba02 (green bar) has moved to the position occupied by right att site in Lambda Ba04. The net effect of this exchange is the creation of new hybrid prophages in CDC 684 (Figure 2B). These observations indicate that the large inversion event did not involve site-directed recombination but rather a homologous recombination event in the interior of both prophages.
Molecular detection of the inversion in other B. anthracis strains
MAMA assays used to detect the CDC 684 chromosomal inversion
Left Inversion Primers
CP Left-inv-F + Right-inv-F
CP Left-inv-F + Left-inv-R
All other B. anthracis
Right Inversion Primers
Left-inv-R + CP Right-inv-R
Right-inv-F + CP Right-inv-R
All other B. anthracis
Status of the Large Inversion Site by PCR or in silico analysis of 18 B. anthracis genomes
Defining the dif site in B. anthracis
In E. coli the large ter region has been found to contain a specific substrate sequence, dif (for Deletion Induced Filamentation), which is used by two recombinases, XerC and XerD, to resolve chromosomal multi-mers and to allow daughter chromosomes to segregate before cell division [30, 31]. It has been proposed that the dif site (a short palindromic sequence) is in fact a more likely site of termination than any specific ter sites for both the E. coli and B. subtilis chromosomes . From the perspective of the CDC 684 genome, the dif sites in both γ-proteobacteria and Firmicutes appear to have an extremely close association with the maximum GC-skew in those genomes that have been analyzed [32, 33].
Chromosomal locations of GC-skew, dif sites and their relative orientation in relationship to the Origin of Replication in complete genomes.
Bc biovar Ba CI
Bc ATCC 14579
Bc ATCC 10987
Ba Ames Ances.
Bt Al Hakam
Growth Kinetics of CDC 684 versus wild type B. anthracis
The significant difference in the spatial orientation of the ori site and dif/GC skew sites in CDC 684 suggests that there could be an alteration in how the bi-directional replication of chromosome would proceed because of the unequal distances the opposite leading strands would need to travel. Because accumulated evidence indicates that genomes like those of E. coli and Bacillus sp do not tolerate significant changes between the spatial orientation of the ori and ter sites, we designed a growth experiment to compare the growth kinetics of CDC 684 to those of three wild type B. anthracis strains.
By phylogenetic, molecular and clinical criteria, CDC 684 is a B. anthracis and its attenuated phenotype must be due to differences within its genome relative to those of other closely related B. anthracis strains. The marked degree of attenuation of CDC 684, (with an LD50 of >1 × 108 spores by the i.m. route in the guinea pig) compares with LD50 values of 175 and 306 spores reported for the virulent Ames and Vollum-1B strains [16, 17]. It therefore renders a comparative genomics approach highly informative and suggests that either subtle SNP differences and/or a dramatic and massive inversion within this chromosome are responsible for the attenuation.
Whole genome sequencing and comparative analysis indicates that there are 51 chromosomal and < 6 plasmid SNP that are unique to CDC 684 in a comparison to Vollum. The possibility that one or more of these rare SNPs may have an important role in the attenuation of CDC 684 remains a viable option. These data have defined a new CDC 684 lineage emanating from the original Vollum branch, Figure 1. Twenty-seven of these SNPs would be translated into non-synonymous mutations in putative gene functions. None of these SNPs, however, are in genes considered to be virulence factors found in opportunistic B. cereus pathogens that include a variety of hemolysins, non-hemolytic enterotoxins, monomeric entertoxins and phospholipases . The remaining 23 SNPs include 11 synonymous SNPs, 7 SNPs in pseudogenes, and 5 intra-genic SNPs. Only one of these intra-genic SNPs is located in a region within a promoter region (-7 bp) in a L-serine dehydratase gene (GBAA_4361).
What has not been excluded from this new lineage are 15 B. anthracis isolates that currently share the nodal position between the CDC 684 and Vollum lineages (see Figure 1). A sequencing effort to identify CDC 684 specific SNP that are either shared or still unique among the presumably virulent 15 isolates would point to phenotype altering SNP. Any chromosomal and plasmid SNP that are still unique to CDC 684 would be candidates for having positions in genes or regulatory regions with roles that govern known or unknown functions that are necessary in a virulent organism. There is, as yet, no clear notion whether or how any of these SNPs could cause the dramatic change in the virulence or growth properties of CDC 684.
The role of the chromosome of B. anthracis in the overall etiology of the disease anthrax is still poorly understood. It is becoming evident that the regulatory functions of the virulent plasmids (pXO1 and pXO2) work in concert with certain chromosomal regulatory functions in a virulent organism, e.g. the regulation of the pXO1 atxA gene by chromosomal sigma factors or plasmid genes involved in a signal-transduction pathway that inhibits sporulation . These and other recent studies  make it difficult to dismiss any of the CDC 684 non-synonymous mutations as candidates for a role in the attenuated phenotype without further analysis.
An alternative hypothesis to explain the attenuation of CDC 684 is a role for the large 3.3 Mbp inversion within its chromosome. While this inversion does not appear to have altered the fine-scale order of the individual genes, it has changed the orientation of the genes within the inversion with respect to the genes outside of the inversion. This change in the orientation has been illustrated by whole genome alignments  and by an analysis of the GC skewing and the location of dif sites of the CDC 684 genome and that of several B. anthracis and B. cereus sub-group isolates (Figure 4, Table 4). These analyses indicate that the spatial relationship between the origin of replication and the termination of replication in CDC 684 has been perturbed by the massive inversion. The comparative growth data (Figure 5) clearly supports the idea that chromosomal replication may be altered in CDC 684 by exhibiting an extended lag phase and a longer growth rate.
The longer DNA synthesis time needed to complete chromosomal replication may be sufficient, alone, to explain the slower cellular growth rate of CDC 684. In the asymmetrical CDC 684 chromosome, the longer leading strand distance is 3.783 Mbp vs. 2.615 Mbp for Vollum and all characterized wild type B. anthracis strains. This is a ~38% larger chromosomal distance to replicate and, assuming everything else remains constant, this will take that much longer to complete the entire chromosome. The mid log doubling time difference between the wild type strains (~80 min) and CDC 684 (~80 min) is ~45%. The similarity between the 38% long replication distance and 45% longer growth rate is striking. This observation suggests that the displaced ter region remains the site for replication termination and that the asymetrical longer leading strand replication distance in CDC 684 becomes limiting for growth in vitro.
Historical accounts suggest that there are strong tendencies to conserve the basic relationship between the position of the ori and ter sites in enteric bacteria . Following the discovery of the dif sites and related specific recombinases, it was proposed that the topological relationship between the ori and the ter/dif site must be maintained at 0° and 180°, respectively, for normal chromosomal segregation to occur . This was suggested because mutations in the Xer recombinase genes or the dif site or the displacement of the dif site to other regions of the chromosome had adverse effects on cell division.
More recently whole genome sequence comparisons between several distinct species also suggest that there is conservation in the spatial orientation between the ori and ter sites over broad groups of bacteria [39–41]. Dot plots of conserved DNA and protein sequences between pairs of species produce characteristic X-shaped patterns suggesting that large chromosomal rearrangements often revolve around and maintain the distances between the origin and the terminus.
This study illustrates a case where the naturally conserved 180° orientation of the ori and ter sites has been modified by a large chromosomal inversion in a strain of B. anthracis, CDC 684. We suggest that the consequence of the altered spatial relationship between the ori and ter sites from 180° to 120° has caused the change in growth kinetics of this isolate (Figure 5). We also suggest that this change appears to alter the length of time that CDC 684 takes to replicates its chromosome. Whether this change has also altered the virulent phenotype of this isolate is yet to be determined.
We address two hypotheses that could have a role for the attenuated phenotype in B. anthracis CDC 684. The first is that a single chromosomal point mutation may have altered a function that is crucial to normal growth and virulence in B. anthracis.
Despite evidence for a wide array of chromosomal rearrangements in the B. cereus subgroup , BLAST searches conducted using the dif region of Bacillus anthracis and B. cereus also indicate a trend towards maintaining a nearly 180° spatial relationship between the ori/dif sites (171°- to 178°, Table 4). The second hypothesis, therefore, suggests that major alterations of this relationship are possibly not tolerated by B. anthracis when under natural ecological pressures. The existence of an isolate like CDC 684 demonstrates that a moderate skewing in the spatial relationship between the ori /dif may be overcome in terms of sheer growth and survivorship in the laboratory. But we suggest that the potential biological consequences of altered DNA replication and/or DNA expression rendered by this change may have resulted in an altered phenotype for successful pathogenicity in a mammalian host. Both kinds of "genetic alterations" can be expected to be rare in B. anthracis since these organisms would not have a selective advantage in a natural environment and would be difficult to find.
Whole genome sequencing and assembly
The genome of B. anthracis CDC 684: Chromosome [GenBank: CP001215.1]. pXO1 [GenBank: CP001216] and pXO2 [GenBank: CP001214] was sequenced at the Joint Genome Institute (JGI)/J. Craig Venter Institute using a combination of 3 kb and 8 kb DNA libraries. All general aspects of library construction and sequencing performed at the JGI can be found at http://www.jgi.doe.gov/. Draft assemblies were based on 59,691 total reads. The Phred/Phrap/Consed software package http://www.phrap.com was used for sequence assembly and quality assessment [43, 44]. After the shotgun stage, reads were assembled with parallel Phrap (High Performance Software, LLC). Possible mis-assemblies were corrected with Dupfinisher  or transposon bombing of bridging clones (Epicentre Biotechnologies, Madison, WI). Gaps between contigs were closed by editing in Consed and by custom primer walking (Roche Applied Science, Indianapolis, IN). A total of 1955 additional custom PCRs were necessary to close gaps and to raise the quality of the finished sequence. The completed genome sequence of B. anthracis str. CDC 684 contains 62,606 reads, achieving an average of 10-fold sequence coverage per base with an error rate of < 10-6.
Experimental animals and spore challenges
Spores were prepared from B. anthracis CDC 684 as previously described  and female Hartley guinea pigs (660 g) were challenged intramuscularly (i.m.) with various spore concentrations (see 'Results') at USAMRIID as previously described [16, 46]. Research was conducted in compliance with the Animal Welfare Act and other federal statutes and regulations relating to experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals (National Research Council. 1996. Guide for the care and use of laboratory animals National Academy Press, Washington, DC.). The facility where this research was conducted is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International.
Canonical SNP (canSNP) Analysis
The thirteen canSNP alleles and the specific assays for each have been described previously . TaqMan™ Minor Groove Binding (MGB) allelic discrimination assays were used to determine the precise canSNP grouping for every isolate used in this study [19, 47].
SYBR MAMA Assays
Additional SNP genotyping was conducted using the Mismatch Amplification Mutation Assay [MAMA] , which is based on allele-specific PCR kinetics , enhanced by penultimate mismatch primer design [29, 49]. The MAMA approach was also used to distinguish the inverted 3.3 Mbp segment of CDC 684 from all other B. anthracis strains. MAMA assays were designed for both the 5' (left) and 3' (right) ends of the inversion; i.e., two sets of primer products separated by 3.3 Mbp. The sequences flanking the 3.3 Mbp inverted region were unique and common to both CDC 684 and the Ames genomes and were defined as Common Primers (CP). But the internal primers targeted nearly identical sequences and therefore used primers designed around mismatches that could distinguish and generate 400 and 500 bp PCR products. The primers were as follows (5' to 3'): Left-inv-R (TAAAGCATCCACATCTTTTAATGgC), Right-inv-F (TTTCTAAAGCATCAACATCTTTTAAAGgT), and CP-Left-inv-F (GCATGTGATTACTTGAAGGATAGAAGG) were used to characterize the left inversion, and Left-inv-R, Right-inv-F and CP-Right-inv-R (5'- AGATTTCCAGTGAGAGATGATAACAACA) targeted the right inversion. Underlined nucleotides overlap the SNP; nucleotides in lowercase represent deliberate penultimate mismatches. The two consensus primers contained no SNPs or incorporated mismatches. Expected inversion genotypes using these primers are listed in Table 2 in the Results section and an example of this assay system is illustrated in Additional File 1.
The MAMA assay system was also used to type 10 new canSNP sites that further define the Vollum lineage of B. anthracis. The primers for these sites are shown in Additional File 2 as a Table.
Each inversion SYBR MAMA reaction comprised 1X SYBR Green Master Mix (Applied Biosystems, Foster City, CA), 0.1 uM MAMA primer, 0.2 uM consensus primer, 0.08 U Platinum Taq polymerase (Invitrogen, Carlsbad, CA) and molecular grade H2O to 9 uL. One uL of genomic DNA was added to each well to a final volume of 10 uL. Reactions were carried out in 384-well optical plates (Applied Biosystems) on an ABI Prism 7900 HT real-time instrument (Applied Biosystems) using the following thermocycling parameters: 2 min at 50°C, 10 min at 95°C, followed by 50 cycles of 15 s at 95°C and 1 min at 60°C. PCR products were subject to post-amplification dissociation (15 sec at 95°C, 15 sec at 60°C, 15 sec at 95°C) to confirm product specificity.
Additional File 1 provides an example of real time PCR profiles for the left inversion region using a fixed Common Primer (CP) that is located outside of the left boundary of the 3.3 Mbp inversion site in both CDC 684 and the Ames genomes. This figure demonstrates real time PCR kinetics for the detection of amplicons for the left boundary of the inversion site in both CDC 684 and the Ames Ancestor Genome using primer combinations described in Table 2.
GC Skew Analysis
A free software program, GenSkew http://genskew.csb.univie.ac.at/, was used to compute the cumulative skew for 15 complete WGS of B. anthracis, B. cereus and B. thuringiensis. These WGS data were downloaded from GenBank: http://www.ncbi.nlm.nih.gov/genbank/.
Stocks of B. anthracis Ames, B. anthracis Vollum (A0488), B anthracis A0361 (a B branch isolate), and B. anthracis CDC 684 were subcultured and grown for ~19 hours on LB agar. These cells were harvested and normalized to OD600 densities that correspond to 105 cfu/mL based on viable count estimates from previous experiments for each isolate. These measurements were used to precisely add 105 cfu inoculums to create 3 ml culture tubes for each isolate. These cultures were grown at 37° C and OD600 measurements were determined on a CO800 Spectrophotometer.
This work was funded in part by the Department of Homeland Security Science and Technology Directorate under contract numbers: NBCH2070001 and HSHQDC-08-C00158. Support for this project was also provide by NAU's Technology and Research Initiative Fund.
- Sternbach G: The history of anthrax. J Emerg Med. 2003, 24 (4): 463-467. 10.1016/S0736-4679(03)00079-9.PubMedView ArticleGoogle Scholar
- Tigertt WD: Anthrax. William Smith Greenfield, M.D., F.R.C.P., Professor Superintendent, The Brown Animal Sanatory Institution (1878-81). J Hyg Camb. 1980, 85: 415-420. 10.1017/S0022172400063488.PubMed CentralPubMedView ArticleGoogle Scholar
- Sterne M: The immunization of laboratory animals against anthrax. Onderstepoort J Vet SciAnim Ind. 1939, 13: 313-317.Google Scholar
- Makino S, Sasakawa C, Uchida I, Terakado N, Yoshikawa M: Cloning and CO2-dependent expression of the genetic region for encapsulation from Bacillus anthracis. Mol Microbiol. 1988, 2 (3): 371-376. 10.1111/j.1365-2958.1988.tb00041.x.PubMedView ArticleGoogle Scholar
- Mikesell P, Ivins B, Ristroph J, Dreier T: Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infection and immunity. 1983, 39 (1): 371.-PubMed CentralPubMedGoogle Scholar
- Okinaka RT, Cloud K, Hampton O, Hoffmaster AR, Hill KK, Keim P, Koehler TM, Lamke G, Kumano S, Mahillon J, et al: Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J Bacteriol. 1999, 181 (20): 6509-6515.PubMed CentralPubMedGoogle Scholar
- Robertson D, Bragg T, Simpson S, Kaspar R, Xie W, Tippetts M: Mapping and characterization of the Bacillus anthracis plasmids. Proceedings of the International Workshop on Anthrax. Edited by: Turnbull P. 1990, Salisbury, UK Salisbury Medical Society, 55-58.Google Scholar
- Robertson DL, Leppla SH: Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis. Gene. 1986, 44 (1): 71-78. 10.1016/0378-1119(86)90044-2.PubMedView ArticleGoogle Scholar
- Tippetts MT, Robertson DL: Molecular cloning and expression of the Bacillus anthracis edema factor toxin gene: a calmodulin-dependent adenylate cyclase. J Bacteriol. 1988, 170 (5): 2263-2266.PubMed CentralPubMedGoogle Scholar
- Vodkin MH, Leppla SH: Cloning of the protective antigen gene of Bacillus anthracis. Cell. 1983, 34 (2): 693-697. 10.1016/0092-8674(83)90402-6.PubMedView ArticleGoogle Scholar
- Welkos S, Lowe J, Eden-McCutchan F, Vodkin M, Leppla S, Schmidt J: Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene. 1988, 69 (2): 287-300. 10.1016/0378-1119(88)90439-8.PubMedView ArticleGoogle Scholar
- Hoffmaster A, Hill K, Gee J, Marston C, De B, Popovic T, Sue D, Wilkins P, Avashia S, Drumgoole R: Characterization of Bacillus cereus isolates associated with fatal pneumonias: strains are closely related to Bacillus anthracis and harbor B. anthracis virulence genes. Journal of clinical microbiology. 2006, 44 (9): 3352.-10.1128/JCM.00561-06.PubMed CentralPubMedView ArticleGoogle Scholar
- Hoffmaster AR, Ravel J, Rasko DA, Chapman GD, Chute MD, Marston CK, De BK, Sacchi CT, Fitzgerald C, Mayer LW, et al: Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc Natl Acad Sci USA. 2004, 101 (22): 8449-8454. 10.1073/pnas.0402414101.PubMed CentralPubMedView ArticleGoogle Scholar
- Klee S, Ozel M, Appel B, Boesch C, Ellerbrok H, Jacob D, Holland G, Leendertz F, Pauli G, Grunow R: Characterization of Bacillus anthracis-like bacteria isolated from wild great apes from Cote d'Ivoire and Cameroon. Journal of bacteriology. 2006, 188 (15): 5333-10.1128/JB.00303-06.PubMed CentralPubMedView ArticleGoogle Scholar
- Ezzell J, Abshire T, Little S, Lidgerding B, Brown C: Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide. Journal of clinical microbiology. 1990, 28 (2): 223.-PubMed CentralPubMedGoogle Scholar
- Ivins B, Welkos S, Knudson G, Little S: Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infection and Immunity. 1990, 58 (2): 303-PubMed CentralPubMedGoogle Scholar
- Ivins BE, Fellows PE, Nelson GO: Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs. Vaccine. 1994, 12: 872-874. 10.1016/0264-410X(94)90027-2.PubMedView ArticleGoogle Scholar
- Pearson T, Busch JD, Ravel J, Read TD, Rhoton SD, U'Ren JM, Simonson TS, Kachur SM, Leadem RR, Cardon ML, et al: Phylogenetic discovery bias in Bacillus anthracis using single-nucleotide polymorphisms from whole-genome sequencing. Proc Natl Acad Sci USA. 2004, 101 (37): 13536-13541. 10.1073/pnas.0403844101.PubMed CentralPubMedView ArticleGoogle Scholar
- Van Ert MN, Easterday WR, Huynh LY, Okinaka RT, Hugh-Jones ME, Ravel J, Zanecki SR, Pearson T, Simonson TS, U'Ren JM, et al: Global genetic population structure of Bacillus anthracis. PLoS One. 2007, 2 (5): e461-10.1371/journal.pone.0000461.PubMed CentralPubMedView ArticleGoogle Scholar
- Manchee RJ, Broster MG, Melling J, Henstridge RM, Stagg AJ: Bacillus anthracis on Gruinard Island. Nature. 1981, 294 (5838): 254-255. 10.1038/294254a0.PubMedView ArticleGoogle Scholar
- Brachman PS: Inhalation anthrax. Ann N Y Acad Sci. 1980, 353: 83-93. 10.1111/j.1749-6632.1980.tb18910.x.PubMedView ArticleGoogle Scholar
- Marston CK, Hoffmaster AR, Wilson KE, Bragg SL, Plikaytis B, Brachman P, Johnson S, Kaufmann AF, Popovic T: Effects of long-term storage on plasmid stability in Bacillus anthracis. Appl Environ Microbiol. 2005, 71 (12): 7778-7780. 10.1128/AEM.71.12.7778-7780.2005.PubMed CentralPubMedView ArticleGoogle Scholar
- Koehler TM: Bacillus anthracis genetics and virulence gene regulation. Curr Top Microbiol Immunol. 2002, 271: 143-164.PubMedGoogle Scholar
- Price L, Hugh-Jones M, Jackson P, Keim P: Genetic diversity in the protective antigen gene of Bacillus anthracis. Journal of bacteriology. 1999, 181 (8): 2358-PubMed CentralPubMedGoogle Scholar
- Keim P, Gruendike JM, Klevytska AM, Schupp JM, Challacombe J, Okinaka R: The genome and variation of Bacillus anthracis. Mol Aspects Med. 2009, 30 (6): 397-405. 10.1016/j.mam.2009.08.005.PubMed CentralPubMedView ArticleGoogle Scholar
- Read TD, Peterson SN, Tourasse N, Baillie LW, Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen JA, Gill SR, et al: The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature. 2003, 423 (6935): 81-86. 10.1038/nature01586.PubMedView ArticleGoogle Scholar
- Sozhamannan S, Chute MD, McAfee FD, Fouts DE, Akmal A, Galloway DR, Mateczun A, Baillie LW, Read TD: The Bacillus anthracis chromosome contains four conserved, excision-proficient, putative prophages. BMC Microbiol. 2006, 6: 34-10.1186/1471-2180-6-34.PubMed CentralPubMedView ArticleGoogle Scholar
- Prescott LM, Harley JP, Klein DA: Microbiology. 1996, Dubuque, IA: Wm. C. Brown Publishers, ThirdGoogle Scholar
- Cha R, Zarbl H, Keohavong P, Thilly W: Mismatch amplification mutation assay (MAMA): application to the cH-ras gene. Genome Research. 1992, 2 (1): 14-10.1101/gr.2.1.14.View ArticleGoogle Scholar
- Blakely G, Colloms S, May G, Burke M, Sherratt D: Escherichia coli XerC recombinase is required for chromosomal segregation at cell division. New Biol. 1991, 3 (8): 789-798.PubMedGoogle Scholar
- Kuempel P, Henson J, Dircks L, Tecklenburg M, Lim D: dif, a recA-independent recombination site in the terminus region of the chromosome of Escherichia coli. The New biologist. 1991, 3 (8): 799-PubMedGoogle Scholar
- Hendrickson H, Lawrence JG: Mutational bias suggests that replication termination occurs near the dif site, not at Ter sites. Molecular Microbiology. 2007, 64 (1): 42-56. 10.1111/j.1365-2958.2007.05596.x.PubMedView ArticleGoogle Scholar
- Carnoy C, Roten C-A: The dif/Xer Recombination Systems in Proteobacteria. PLoS ONE. 2009, 4 (9): e6531-10.1371/journal.pone.0006531.PubMed CentralPubMedView ArticleGoogle Scholar
- Yen M, Lin N, Hung C, Choy K, Weng S, Tseng Y: oriC region and replication termination site, dif, of the Xanthomonas campestris pv. campestris 17 chromosome. Applied and environmental microbiology. 2002, 68 (6): 2924-10.1128/AEM.68.6.2924-2933.2002.PubMed CentralPubMedView ArticleGoogle Scholar
- Sergeev N, Distler M, Vargas M, Chizhikov V, Herold KE, Rasooly A: MIcroarray analysis of Bacillus cereus group virulence factors. Journal of Microbiological Methods. 2006, 65: 488-502. 10.1016/j.mimet.2005.09.013.PubMedView ArticleGoogle Scholar
- Perego M, Hoch JA: Commingling regulatory systems following acquisition of virulence plasmids by Bacillus anthracis. Trends Microbiol. 2008, 16 (5): 215-221. 10.1016/j.tim.2008.01.010.PubMedView ArticleGoogle Scholar
- Chiang C, Bongiorni C, Perego M: Glucose-dependent activation of Bacillus anthracis toxin gene expression and virulence requires the carbon catabolite protein CcpA. J Bacteriol. 2011, 193 (1): 52-62. 10.1128/JB.01656-09.PubMed CentralPubMedView ArticleGoogle Scholar
- Liu SL, Sanderson KE: The chromosome of Salmonella paratyphi A is inverted by recombination between rrnH and rrnG. J Bacteriol. 1995, 177 (22): 6585-6592.PubMed CentralPubMedGoogle Scholar
- Eisen JA, Heidelberg JF, White O, Salzberg SL: Evidence for symmetric chromosomal inversions around the replication of origin in bacteria. Genome Biology. 2000, 1 (6): 1-9.View ArticleGoogle Scholar
- Tillier ER, Collins RA: Genome rearrangement by replication-directed translocation. Nat Genet. 2000, 26 (2): 195-197. 10.1038/79918.PubMedView ArticleGoogle Scholar
- Worning P, Hensen LJ, Hallin PF, Staerfeldt H-H, Ussery DW: Origins of replication in circular prokaryotic chromosomes. Environmental Microbiology. 2006, 8 (2): 353-361. 10.1111/j.1462-2920.2005.00917.x.PubMedView ArticleGoogle Scholar
- Carlson CR, Kolsto AB: A complete physical map of a Bacillus thuringiensis chromosome. J Bacteriol. 1993, 175 (4): 1053-1060.PubMed CentralPubMedGoogle Scholar
- Ewing B, Green P: Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998, 8 (3): 186-194.PubMedView ArticleGoogle Scholar
- Ewing B, Hillier L, Wendl MC, Green P: Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998, 8 (3): 175-185.PubMedView ArticleGoogle Scholar
- Han CS, Xie G, Challacombe JF, Altherr MR, Bhotika SS, Brown N, Bruce D, Campbell CS, Campbell ML, Chen J, et al: Pathogenomic sequence analysis of Bacillus cereus and Bacillus thuringiensis isolates closely related to Bacillus anthracis. J Bacteriol. 2006, 188 (9): 3382-3390. 10.1128/JB.188.9.3382-3390.2006.PubMed CentralPubMedView ArticleGoogle Scholar
- Ivins BE, Ezzell JW, Jemski J, Hedlund KW, Ristroph JD, Leppla SH: Immunization studies with attenuated strains of Bacillus anthracis. Infect Immun. 1986, 52 (2): 454-458.PubMed CentralPubMedGoogle Scholar
- Morin PA, Saiz R, Monjazeb A: High-throughput single nucleotide polymorphism genotyping by fluorescent 5' exonuclease assay. Biotechniques. 1999, 27 (3): 538-540. 542, 544 passimPubMedGoogle Scholar
- Huang MM, Arnheim N, Goodman MF: Extension of base mispairs by Taq DNA polymerase: implications for single nucleotide discrimination in PCR. Nucleic Acids Res. 1992, 20 (17): 4567-4573. 10.1093/nar/20.17.4567.PubMed CentralPubMedView ArticleGoogle Scholar
- Rhodes RB, Lewis K, Shultz J, Huber S, Voelkerding KV, Leonard DG, Tsongalis GJ, Kephart DD: Analysis of the factor V Leiden mutation using the READIT Assay. Mol Diagn. 2001, 6 (1): 55-61. 10.2165/00066982-200106010-00007.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.